ligand


Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to ligand

a substance (an atom or molecule or radical or ion) that forms a complex around a central atom

Related Words

References in periodicals archive ?
As a result of achieving this milestone, Ligand will receive a $1 million payment from its European marketing and distribution partner Elan.
Ligand discovers and develops new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases.
And if the cells [of a transplanted organ] express Fas ligand, it is protected from the immune system.
There are currently no approved TPO molecules available but there are both peptides and oral TPO mimetics in late-stage clinical development, the latter class including molecules developed by GSK in collaboration with Ligand.
Ligand disclaims any intent of obligation to update these forward-looking statements beyond the date of this release.
Computational ligand design: Pharmacophore modeling, ligand-based approaches, structure-based approaches, de novo ligand design and design software.
The sale of our real estate assets will provide additional working capital as we transition to a refocused Ligand built upon our targeted internal research and development effort and broad partnered product pipelines," said Henry F.
In that event, the Rights permit Ligand stockholders, other than the acquiring person, to purchase Ligand Common Stock having a market value of twice the exercise price of the Rights, in lieu of the Preferred Stock.
SAN DIEGO -- Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) (the "Company" or "Ligand") announced today that it has signed a definitive asset purchase agreement to transfer the assets associated with AVINZA (morphine sulfate extended-release capsules) to King Pharmaceuticals, Inc.
SAN DIEGO -- Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) (the "Company" or "Ligand") is pleased to announce today that it has signed a definitive agreement to sell its oncology product line and the associated assets to Eisai Co.
SAN DIEGO -- Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) (the "Company" or "Ligand") announced today that it has reached agreement to settle the securities class action litigation filed in the United States District Court for the Southern District of California against the Company and certain of its directors and officers.
SAN DIEGO -- Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) (the "Company" or "Ligand") announced today that it has earned from Wyeth (NYSE:WYE) a milestone payment of an undisclosed amount as a result of Wyeth's confirmation of submission on June 23, 2006, of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for bazedoxifene investigated as a postmenopausal osteoporosis therapy.
SAN DIEGO -- Ligand Pharmaceuticals Incorporated (Pink Sheets:LGND) today announced that NASDAQ has approved the company's application for relisting its common stock on the NASDAQ National Market.
SAN DIEGO -- Ligand Pharmaceuticals Incorporated (Pink Sheets:LGND) (the "Company" or "Ligand") -- Results of retrospective analysis in large trials in first line NSCLC and final analysis of a 3rd line NSCLC trial were presented Sunday, June 4th at the annual meeting of the American Society of Clinical Oncology (ASCO) in Atlanta.
Full browser ?